Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: A multi-institutional retrospective cohort study - Luca Antonelli, Davide Ardizzone, Praful Ravi, Christopher Sweeney, Aditya Bagrodia, Michal Mego, Sia Daneshmand, T. Campanelli Palmer, Sebastiano Nazzani, Patrizia Giannatempo, Andrea Franza, Axel Heidenreich, Pia Paffenholz, Ragheed Saoud, Antoin Douglawi - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

Published in

Elsevier, European Urology Open Science, (45), p. S53, 2022

DOI: 10.1016/s2666-1683(22)02456-9

Links

ORCID
Elsevier | PDF

Tools

Export citation

Search in Google Scholar

Risk of residual teratoma after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumor and IGCCCG intermediate/poor prognosis: A multi-institutional retrospective cohort study

Journal article published in 2022 by Luca Antonelli, Davide Ardizzone, Praful Ravi, Christopher Sweeney, Aditya Bagrodia, Michal Mego, Sia Daneshmand, T. Campanelli Palmer, Sebastiano Nazzani, Patrizia Giannatempo, Andrea Franza, Axel Heidenreich, Pia Paffenholz, Ragheed Saoud, Antoin Douglawi and other authors.

This paper is made freely available by the publisher.

This paper is made freely available by the publisher.

Full text: Download

Green circle

Preprint: archiving allowed

Upload

Green circle

Postprint: archiving allowed

Upload

Green circle

Published version: archiving allowed

Upload

Policy details

Data provided by

SHERPA/RoMEO